Immune Design Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Immune Design (IMDZ) Tops Q3 EPS by 2c
November 12, 2015 4:44 PM ESTImmune Design (NASDAQ: IMDZ) reported Q3 EPS of ($0.37), $0.02 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.1 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More